心脏性休克:诊断,表型和管理
Jacob Eifer Møller1,2, Christian Hassager3,4, Alastair Proudfoot5
1Department of Cardiology, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark. jacob.moeller1@rsyd.dk.
Intensive care medicine
|August 6, 2025
概括
精准医学通过整合患者数据,为心脏性休克 (CS) 提供量身定制的治疗方法. 来自试验的严格证据对于在CS护理中平衡创新与患者安全至关重要.
科学领域:
- 心脏病学 心脏病学
- 关键护理医学 关键护理医学
- 精准医学是一门精准的医学.
背景情况:
- 心脏性休克 (CS) 是一种危及生命的疾病,其特点是由于心力衰竭而导致严重的末端器官低输液.
- 高死亡率凸显了急需改进CS治疗策略的迫切需要.
- 当前的治疗模式正在随着技术的进步和个性化医疗方法的发展而发展.
研究的目的:
- 探索精准医学的潜力,以量身定制心脏性休克干预措施.
- 突出整合各种患者数据 (遗传,生物标志物,成像,临床) 对于个性化CS管理的重要性.
- 强调基于证据的新疗法融入临床实践的必要性.
主要方法:
- 对血液动力学监测和机械循环支持领域新兴技术的审查.
- 分析针对CS的向药理疗法的进展.
- 讨论从临床试验,注册表和元分析中整合数据的作用.
主要成果:
- 精准医学对个性化CS治疗策略具有前景.
- 新的血液动力学监测,先进的机械支持和向药物扩大了治疗选择.
- 整合这些创新需要通过强有力的临床证据进行仔细验证.
结论:
- 建议在CS管理中转向以患者为中心,细微的方法.
- 将创新与科学严谨性平衡,特别是随机对照试验,对于患者的安全性和有效性至关重要.
- 合作努力和数据共享至关重要,以推进基于证据的精准医学在心脏性休克.
相关概念视频
Cardiomyopathy III: Hypertrophic Cardiomyopathy
48
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
48
Cardiomyopathy II: Dilated Cardiomyopathy
22
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
22
Cardiomyopathy V: Interprofessional Care
34
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
34
Cardiomyopathy VI: Nursing Management
42
Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
42
Cardiopulmonary Resuscitation IV: Pharmacological Management
77
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
77
Cardiomyopathy I: Introduction and Classification
56
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
56


